March 20, 2023 3:45 PM
Latest:
  • Jim Cramer Calls For First Republic Bank To Be Placed Into Receivership
  • Credit Suisse: Bondholders Left Empty-Handed While Equity Holders Get Paid
  • BC, Ontario Taxes Rumored To Approach 60% In New Budget
  • The Fed’s Balance Sheet Is Overstated — With Tavi Costa
  • Amazon Preparing To Lay Off Another 9,000 Workers
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Thank you!

You have successfully joined our subscriber list.

.

  • Home
  • Latest
    • Automotive
    • Briefing
    • Cannabis
    • Commentary
    • Education
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Psychedelics
    • Resources
    • Technology
  • Cannabis
  • Technology
  • Company Profiles
    • Hemlo Explorers
    • HydroGraph Clean Power
    • Power Nickel
    • Prime Meridian Resources
    • Riverside Resources
    • RooGold Inc
    • Slave Lake Zinc
    • Spey Resources
    • Trillion Energy
    • Vortex Metals
  • Resources
  • About
  • Contact Us
  • Advertise With Us

MindMed

Biotech Briefing 

MindMed Expects Results For Anxiety, ADHD Trials By Late 2023

January 9, 2023 10:40 AMJanuary 9, 2023 10:40 AM ER Velasco 0 Comments Mind Medicine, MindMed

It seems it is business as usual for Mind Medicine, aka MindMed, (NASDAQ: MNMD) as the firm gave updates on

Share
Tweet
Share
Read more
Biotech Briefing 

Activist Investor Calls For MindMed CEO’s Termination Due To Alleged Fraudulent Acts

November 3, 2022 3:10 PMNovember 3, 2022 1:59 PM ER Velasco 0 Comments Mind Medicine, MindMed

FCM MM Holdings, one of Mind Medicine’s (NEO: MMED) shareholders with a 6.1% stake, has formally filed a complaint with

Share
Tweet
Share
Read more
Biotech Briefing 

Mindmed: Canaccord Calls Financing “Puzzling And Unusual”

October 1, 2022 1:04 PMOctober 1, 2022 7:59 AM Justin Young 0 Comments Analyst Estimate, Mind Medicine, MindMed

This past week Mind Medicine Inc. (NEO: MMED) announced that they would be doing a public offering of 7,058,823 units

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mind Medicine Prices $30 Million Offering At 30% Discount To Market

September 28, 2022 9:28 AMSeptember 28, 2022 9:28 AM Jay Lutz 0 Comments Mind Medicine, MindMed

Mind Medicine (NEO: MMED) has elected to destroy shareholder value in a major way this morning, pricing yet another financing

Share
Tweet
Share
Read more
Biotech Briefing 

MindMed Starts Dosing Patients In Phase 1 Clinical Study On MDMA-Like Substances

September 21, 2022 11:23 AMSeptember 21, 2022 10:33 AM ER Velasco 0 Comments Mind Medicine, MindMed

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Tuesday that the first patient has been dosed

Share
Tweet
Share
Read more
Biotech Briefing 

MindMed Sees Positive Results For Its LSD Treatment For Anxiety Disorders Published In Peer-Reviewed Journal

September 8, 2022 5:03 PMSeptember 8, 2022 4:31 PM ER Velasco 0 Comments Mind Medicine, MindMed

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Thursday that the previously released positive topline data

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mindmed Completes 15-To-1 Reverse Split To Maintain Nasdaq Compliance

August 29, 2022 8:21 AMAugust 29, 2022 8:22 AM Jay Lutz 0 Comments Mind Medicine, MindMed

Mind Medicine (NEO: MMED) might be slightly more volatile over the next few sessions. The psychedelic firm late on Friday

Share
Tweet
Share
Read more
Briefing Psychedelics Retail 

20-Year-Old Makes $110 Million From Bed Bath & Beyond Stock.. Next Stop: MindMed

August 18, 2022 9:26 AMAugust 18, 2022 10:13 AM JP Alegre 0 Comments Bed Bath and Beyond, Jake Freeman, Meme Stocks, MindMed

20-year-old Jake Freeman just walked away with around $110 million from selling his 6.21% stake in meme-stock favorite Bed Bath

Share
Tweet
Share
Read more
Biotech Briefing Psychedelics 

MindMed Declares US$17.0 Million Net Loss, US$105.7 Million Cash Balance For Q2 2022

August 12, 2022 8:20 AMAugust 12, 2022 8:20 AM ER Velasco 0 Comments Mind Medicine, MindMed

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Thursday its financial results for Q2 2022. The

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mind Medicine Sees Co-Founder Become An Activist Shareholder Demanding Changes

August 11, 2022 8:41 AMAugust 11, 2022 8:42 AM Jay Lutz 0 Comments Mind Medicine, MindMed

An activist shareholder battle might be brewing at Mind Medicine (NEO: MMED). This morning, co-founder of the company Dr Scott

Share
Tweet
Share
Read more
  • ← Previous

Briefings

Jim Cramer Calls For First Republic Bank To Be Placed Into Receivership
Briefing Macro 

Jim Cramer Calls For First Republic Bank To Be Placed Into Receivership

March 20, 2023 3:08 PM Jay Lutz 0

Jim Cramer is looking for solutions to calm the ongoing financial sector crisis, with his latest call being to ringfence

Credit Suisse: Bondholders Left Empty-Handed While Equity Holders Get Paid
Briefing Macro 

Credit Suisse: Bondholders Left Empty-Handed While Equity Holders Get Paid

March 20, 2023 3:03 PM Jim McFadden 0
BC, Ontario Taxes Rumored To Approach 60% In New Budget
Briefing Macro 

BC, Ontario Taxes Rumored To Approach 60% In New Budget

March 20, 2023 2:24 PM ER Velasco 0
The Fed’s Balance Sheet Is Overstated — With Tavi Costa
Briefing Macro Video Series 

The Fed’s Balance Sheet Is Overstated — With Tavi Costa

March 20, 2023 1:30 PM Jay Lutz 0
Amazon Preparing To Lay Off Another 9,000 Workers
Briefing Macro Technology 

Amazon Preparing To Lay Off Another 9,000 Workers

March 20, 2023 1:14 PM Hermina Paull 0
Russia’s Wagner Group Suspected of Gunning Down Chinese Nationals at African Gold Mine
Briefing Politics Resources 

Russia’s Wagner Group Suspected of Gunning Down Chinese Nationals at African Gold Mine

March 20, 2023 12:40 PM Hermina Paull 0
David Sacks vs. Marc Cohodes, Explained
Briefing Macro 

David Sacks vs. Marc Cohodes, Explained

March 20, 2023 11:41 AM ER Velasco 0

Spotlight Series

The Fed’s Balance Sheet Is Overstated — With Tavi Costa
Briefing Macro Video Series 

The Fed’s Balance Sheet Is Overstated — With Tavi Costa

March 20, 2023 1:30 PM Jay Lutz 0

The Daily Dive opens this week with regular guest Tavi Costa, Partner & Portfolio Manager for Crescat Capital. Tavi joins

News

First Phosphate Recovers 91.4% Of Apatite In Metallurgy Tests, Produces 40.2% P2O5 Concentrate
Briefing News Resources 

First Phosphate Recovers 91.4% Of Apatite In Metallurgy Tests, Produces 40.2% P2O5 Concentrate

March 20, 2023 9:28 AM Jay Lutz 0

Early metallurgy results are in for First Phosphate (CSE: PHOS) in conjunction with an ongoing preliminary economic assessment being conducted

Eguana Sees ITOCHU Increase Stake To 12.95%
Briefing News Technology 

Eguana Sees ITOCHU Increase Stake To 12.95%

March 16, 2023 9:00 AM Jay Lutz 0
Carlyle Commodities Hits 689 Metres Of 0.51 g/t Gold
Briefing News Resources 

Carlyle Commodities Hits 689 Metres Of 0.51 g/t Gold

March 15, 2023 10:06 AM Jay Lutz 0
First Phosphate: New Report Suggests Flagship Property Holds ESG-Compliant Source Of Phosphate For LFP Battery Industry
Briefing News Resources 

First Phosphate: New Report Suggests Flagship Property Holds ESG-Compliant Source Of Phosphate For LFP Battery Industry

March 14, 2023 11:22 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Blockchain
  • Bonds
  • Briefing
  • Cannabis
  • Commentary
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2023 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.